Researchers continue to excited about Retatrutide , a innovative dual compound showing significant results in clinical trials for body loss . It functions by modulating two pathways : GLP-1 and GIP, these, when stimulated, support control hunger and enhance energy expenditure . Initial findings indicate noteworthy size loss and likely benefits for